News Daily News Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI Michael O'Riordan April 22, 2025
News Daily News Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2 Michael O'Riordan June 14, 2023
News Daily News A Simple Nudge Moves the Needle on Statin Prescribing Michael O'Riordan December 02, 2022
News Daily News For Coronary Heart Disease, Upping Exercise Over Time Linked to Survival Gains Michael O'Riordan May 03, 2022
News Daily News USPSTF: Data Around Screening for AF in Asymptomatic Adults Still Lacking Todd Neale January 25, 2022
News Daily News Long-term Anticoagulation After Unprovoked VTE: New Insights Shelley Wood September 13, 2021
News Daily News Vitamin D, Calcium, Other Vitamins, and Supplements Do Not Prevent CVD Michael O'Riordan January 25, 2021
News Daily News ESC and EACTS Announce Review of Left Main Revascularization Guidelines Michael O'Riordan October 06, 2020
News Daily News Cholesterol Guidelines Fail Young MI Patients Who Might Have Benefited From Statins L.A. McKeown August 04, 2020
News Daily News New EXCEL Analysis Reignites Debate Over PCI for Left Main CAD Michael O'Riordan June 01, 2020
News Daily News Meta-analysis Questions PCI vs CABG in Women With Multivessel Disease Shelley Wood February 27, 2020
News Daily News SYNTAX Score Predicts Long-term Benefits of Left Main PCI and CABG: MAIN-COMPARE Michael O'Riordan February 03, 2020
News Daily News CvLPRIT: Long-term Reduction in Death/MI With Complete Revascularization Michael O'Riordan December 20, 2019
News Daily News EACTS Pulls Out of Left Main Guidelines After BBC Bombshell Alleging EXCEL Trial Cover-up Michael O'Riordan December 10, 2019
News Daily News Field in Flux: What’s the Best Antithrombotic Strategy for A-fib Patients Undergoing PCI? Michael O'Riordan July 03, 2019
News Daily News Early Invasive Strategy Benefits Select High-Risk NSTE ACS Patients, Meta-analysis Suggests Michael O'Riordan August 14, 2017
News Daily News European Societies Release Updated Revascularization Guidelines for CAD L.A. McKeown September 11, 2014